| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5386 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1081 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 824 | 2022 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 564 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 431 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 357 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 312 | 2021 |
| Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model AR Wargo, S Huijben, JC De Roode, J Shepherd, AF Read Proceedings of the National Academy of Sciences 104 (50), 19914-19919, 2007 | 203 | 2007 |
| A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research SJ Rihn, A Merits, S Bakshi, ML Turnbull, A Wickenhagen, AJT Alexander, ... PLoS biology 19 (2), e3001091, 2021 | 187 | 2021 |
| Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health, 8 January 2021 World Health Organization World Health Organization, 2021 | 147 | 2021 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 120 | 2021 |
| The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... BioRxiv, 2020.11. 04.355842, 2020 | 107 | 2020 |
| Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland A da Silva Filipe, JG Shepherd, T Williams, J Hughes, E Aranday-Cortes, ... Nature Microbiology 6 (1), 112-122, 2021 | 102 | 2021 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 63 | 2021 |
| Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data MD Parker, BB Lindsey, S Leary, S Gaudieri, A Chopra, M Wyles, ... Genome research 31 (4), 645-658, 2021 | 48 | 2021 |
| Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data O Stirrup, J Hughes, M Parker, DG Partridge, JG Shepherd, J Blackstone, ... Elife 10, e65828, 2021 | 40 | 2021 |
| Non-epidemic HCV genotypes in low-and middle-income countries and the risk of resistance to current direct-acting antiviral regimens R Shah, L Ahovegbe, M Niebel, J Shepherd, EC Thomson Journal of hepatology 75 (2), 462-473, 2021 | 36 | 2021 |
| Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence ADS Filipe, J Shepherd, T Williams, J Hughes, E Aranday-Cortes, ... MedRxiv, 2020.06. 08.20124834, 2020 | 27 | 2020 |
| Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission LB Snell, CL Fisher, U Taj, O Stirrup, B Merrick, A Alcolea-Medina, ... Clinical Microbiology and Infection 28 (1), 93-100, 2022 | 26 | 2022 |
| Platelet receptor polymorphisms do not influence Staphylococcus aureus–platelet interactions or infective endocarditis S Daga, JG Shepherd, JGS Callaghan, RKY Hung, DK Dawson, ... Microbes and infection 13 (3), 216-225, 2011 | 26 | 2011 |
Emma ThomsonProfessor of Infectious Diseases在 doctors.org.uk 的电子邮件经过验证
Emma ThomsonProfessor of Infectious Diseases在 doctors.org.uk 的电子邮件经过验证
J. Ross FitzgeraldUniversity of Edinburgh在 ed.ac.uk 的电子邮件经过验证